Optometrist · Louisville, KY
NPI
1679190060
Since 2020
Specialty
Optometrist
Code 152W00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
9200 Leesgate Rd Ste 100
Louisville, KY, 40222
Phone (502) 895-0040
Groups this clinician bills Medicare through
Medicare paid, 2024
$106K
1,702 services
Medicare patients, 2024
787
Average age 75
Drug cost, 2024
$494K
1,218 prescriptions
Company payments, 2025
$1,885
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by William T Gibson was code 99213 (office e&m - established), 694 times for 477 patients. In total William T Gibson billed 1,702 services in 24 codes, and Medicare paid $106K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-11-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 694 | 477 | $63.84 | $44K |
| 99214 Office E&M - Established | Office | 226 | 180 | $82.43 | $19K |
| 92134 Computerized Ophthalmic Imaging | Office | 141 | 120 | $27.64 | $3,898 |
| 92014 Ophthalmological E&M | Office | 118 | 118 | $86.01 | $10K |
| 92250 Angiography | Office | 90 | 87 | $26.05 | $2,344 |
| 92083 Vision, Hearing, and Speech Services | Office | 88 | 87 | $44.15 | $3,885 |
| 92133 Computerized Ophthalmic Imaging | Office | 74 | 69 | $22.34 | $1,653 |
| 92004 Ophthalmological E&M | Office | 59 | 59 | $93.51 | $5,517 |
| 99203 Office E&M - New | Office | 50 | 50 | $70.29 | $3,514 |
| 68761 Eye | Office | 41 | 38 | $145.18 | $5,952 |
| 99204 Office E&M - New | Office | 29 | 29 | $117.65 | $3,412 |
| 76514 Ultrasound - Nonspecific | Office | 25 | 25 | $7.74 | $193 |
| 67820 Eye | Office | 14 | 13 | $14.64 | $205 |
By year: 2022 $32K for 460 services; 2023 $72K for 1,062 services; 2024 $106K for 1,702 services.
Medicare prescription drug claims, 2024
In 2024, the drug William T Gibson prescribed most often to Medicare patients was Tobramycin-Dexamethasone (Tobramycin/Dexamethasone), with 172 prescriptions and refills. In total William T Gibson wrote 1,218 Medicare prescriptions that cost $494K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 172 | 173 | 149 | $6,719 |
| Xdemvy Lotilaner | 136 | 193 | 132 | $252K |
| Prednisolone Acetate Generic | 111 | 127 | 84 | $3,634 |
| Latanoprost Generic | 111 | 256 | 44 | $1,260 |
| Loteprednol Etabonate Generic | 77 | 87 | 50 | $9,518 |
| Timolol Maleate Generic | 65 | 145 | 31 | $506 |
| Cequa Cyclosporine | 57 | 70 | 25 | $39K |
| Brimonidine Tartrate Generic | 45 | 63 | 29 | $1,256 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 43 | 45 | 38 | $418 |
| Xiidra Lifitegrast | 43 | 94 | 26 | $64K |
| Tyrvaya Varenicline Tartrate | 40 | 40 | Under 11 | $26K |
| Doxycycline Monohydrate Generic | 37 | 37 | 35 | $773 |
| Restasis Cyclosporine | 33 | 76 | 23 | $47K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 27 | 74 | 12 | $857 |
| Simbrinza Brinzolamide/Brimonidine Tart | 22 | 22 | Under 11 | $4,405 |
Brand drugs: 653 claims; generic drugs: 565 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid William T Gibson $1,885 ($1,885 in general payments such as food, travel and fees) from 13 companies. The largest payer was Tarsus Pharmaceuticals, Inc. with $673.
| Company | Payments | Amount |
|---|---|---|
| Tarsus Pharmaceuticals, Inc. TARS | 20 | $673 |
| Amgen Inc. AMGN | 7 | $216 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 6 | $192 |
| Harrow Eye, LLC | 3 | $169 |
| Bausch & Lomb Americas Inc. BLCO | 8 | $146 |
| Glaukos Corporation GKOS | 1 | $128 |
| Abbvie Inc. ABBV | 5 | $126 |
| Dompe US, Inc. | 4 | $97.37 |
| Oyster Point Pharma, Inc. | 2 | $40.4 |
| Alcon Vision LLC ALC | 1 | $30.26 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.